Spotlight - Information about FUJIFILM Europe

Spotlight 47: Promoting R&D of anti-cancer drugs

Cancer TreatmentOur business strategy for future growth is to focus on developing innovative drugs that address unmet medical needs. Fujifilm is defining oncology as its focal area and is promoting the R&D of anti-cancer drugs by combining the technologies and experiences including chemical synthesis capacity, design ability, analysis technology accumulated through the development and production of photographic film. For the new anti-cancer drug FF-10101 the company has just announced to start a Phase I clinical trial in the United States in patients with relapsed or refractory Acute Myeloid Leukemia (AML).

More about anti-cancer drug FF-10101